BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7631046)

  • 1. Interactions of the vasoconstrictor peptides, angiotensin II and endothelin-1, with vasodilatory prostaglandins.
    Schramek H; Coroneos E; Dunn MJ
    Semin Nephrol; 1995 May; 15(3):195-204. PubMed ID: 7631046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin I2 and the kidney.
    Dunn MJ
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():27-31. PubMed ID: 2514664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive substances as regulators of renal growth.
    Wolf G
    Exp Nephrol; 1993; 1(3):141-51. PubMed ID: 8081963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of the nephrotoxicity of non-steroidal anti-inflammatory drugs.
    Dunn MJ; Scharschmidt L; Zambraski E
    Arch Toxicol Suppl; 1984; 7():328-37. PubMed ID: 6595999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin-mediated actions of the renin-angiotensin system.
    Schrör K
    Arzneimittelforschung; 1993 Feb; 43(2A):236-41. PubMed ID: 8498970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid derivatives and renal function in liver cirrhosis.
    Laffi G; La Villa G; Pinzani M; Marra F; Gentilini P
    Semin Nephrol; 1997 Nov; 17(6):530-48. PubMed ID: 9353864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II sensitivity of afferent glomerular arterioles in endothelin-1 transgenic mice.
    Patzak A; Bontscho J; Lai E; Kupsch E; Skalweit A; Richter CM; Zimmermann M; Thöne-Reineke C; Joehren O; Godes M; Steege A; Hocher B
    Nephrol Dial Transplant; 2005 Dec; 20(12):2681-9. PubMed ID: 16188896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of salt intake and angiotensin II on vascular reactivity to endothelin-1.
    Ballew JR; Watts SW; Fink GD
    J Pharmacol Exp Ther; 2001 Feb; 296(2):345-50. PubMed ID: 11160616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoconstrictive peptides induce endothelin-1 and prostanoids in human cerebromicrovascular endothelium.
    Spatz M; Stanimirovic D; Bacic F; Uematsu S; McCarron RM
    Am J Physiol; 1994 Mar; 266(3 Pt 1):C654-60. PubMed ID: 8166228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II-induced constrictions are masked by bovine retinal vessels.
    Kulkarni PS; Hamid H; Barati M; Butulija D
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):721-8. PubMed ID: 10067976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II exerts positive feedback on the intrarenal renin-angiotensin system by an angiotensin converting enzyme-dependent mechanism.
    Sadjadi J; Kramer GL; Yu CH; Welborn MB; Modrall JG
    J Surg Res; 2005 Dec; 129(2):272-7. PubMed ID: 15992826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contractile effects of angiotensin peptides in rat aorta are differentially dependent on tyrosine kinase activity.
    Petrescu G; Costuleanu M; Slatineanu SM; Costuleanu N; Foia L; Costuleanu A
    J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):180-7. PubMed ID: 11881120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents.
    Camarda V; Rizzi A; Calò G; Gendron G; Perron SI; Kostenis E; Zamboni P; Mascoli F; Regoli D
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):141-9. PubMed ID: 11819032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Angiotensin II-induced endothelin-1 release in cardiac myocytes].
    Villa-Abrille MC; Cingolani HE; Garciarena CD; Ennis IL; Aiello EA
    Medicina (B Aires); 2006; 66(3):229-36. PubMed ID: 16871910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
    Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
    Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
    Gardiner SM; Kemp PA; Brunner-Ferber F; Bennett T
    Br J Pharmacol; 1997 Dec; 122(8):1687-93. PubMed ID: 9422815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of perindopril on renal medullary hemodynamics in genetically hypertensive rats.
    Liu KL; Lo M; Benzoni D
    Am J Hypertens; 2006 Jun; 19(6):617-22. PubMed ID: 16733235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of peptide vasoconstrictors on vessel structure.
    Hahn AW; Resink TJ; Mackie E; Scott-Burden T; Bühler FR
    Am J Med; 1993 Apr; 94(4A):13S-19S. PubMed ID: 8488851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of endothelin on hemodynamics, prostaglandins, blood coagulation and renal function.
    Schulz E; Ruschitzka F; Lueders S; Heydenbluth R; Schrader J; Müller GA
    Kidney Int; 1995 Mar; 47(3):795-801. PubMed ID: 7752579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the reaction sequence involved in phospholipid labeling and deacylation and prostaglandin synthesis and actions.
    Needleman P
    J Allergy Clin Immunol; 1978 Aug; 62(2):96-102. PubMed ID: 97337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.